SHANGHAI, Oct. 15, 2024 (GLOBE NEWSWIRE) — On October 13, UnionPay International (UPI) and the National Payment Corporation of Vietnam (NAPAS) signed a Memorandum of Understanding (MOU) in Hanoi. Both parties agree to deepen the collaboration on cross-border QR code interoperability and enable QR payments by UnionPay and Vietnamese local bank applications/e-wallets on each other’s […]
Levi & Korsinsky, LLP notifies investors in Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stellantis investors who were adversely affected by alleged securities fraud between February 15, 2024 and July 24, 2024. Follow the link below
Levi &Korsinsky, LLP notifies investors in iLearningEngines, Inc. (“iLearningEngines” or the “Company”) (NASDAQ: AILE) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iLearningEngines investors who were adversely affected by alleged securities fraud between April 22, 2024 and August 28, 2024. Follow the link below to
Levi &Korsinsky, LLP notifies investors in DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all investors who: (i) purchased or otherwise
Levi &Korsinsky, LLP notifies investors in STMicroelectronics N.V. (“STMicroelectronics” or the “Company”) (NYSE: STM) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of STMicroelectronics investors who were adversely affected by alleged securities fraud between January 25, 2024 and July 24, 2024. Follow the link below to
Levi &Korsinsky, LLP notifies investors in Terran Orbital Corporation (“Terran” or the “Company”) (NYSE: LLAP) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Terran investors who were adversely affected by alleged securities fraud between August 15, 2023 and August 14, 2024. Follow the link below
Levi & Korsinsky, LLP notifies investors in Agenus Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Agenus investors who were adversely affected by alleged securities fraud between January 23, 2023 and July 17, 2024. Follow the link below
Levi & Korsinsky, LLP notifies investors in Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Super Micro investors who were adversely affected by alleged securities fraud between February 2, 2021 and September 25, 2024.
Levi & Korsinsky, LLP notifies investors in New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of New Fortress investors who were adversely affected by alleged securities fraud between February 29, 2024 and August 8, 2024.
Levi &Korsinsky, LLP notifies investors in Verve Therapeutics, Inc. (“Verve Therapeutics” or the “Company”) (NASDAQ: VERV) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Verve Therapeutics investors who were adversely affected by alleged securities fraud between August 9, 2022 and April 1, 2024. Follow the